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The Hedgehog (Hh) pathway is important for skeletal patterning andmorphogenesis during embryonic devel-
opment. Papers by Ohba et al. and Mak et al. in this edition of Developmental Cell suggest that Hh signaling
may exert delicate control over the activities of osteoclasts and osteoblasts, the cell types primarily respon-
sible for bone resorption and formation.‘‘When Hedgehogs mate, they do
so verrrry carefully.’’
The activities of osteoclasts and osteo-
blasts are linked and highly coordinated.
The responsible mechanisms remain
mysterious, although all bone diseases
are associated with disruption of these
coordinated activities, and all drugs
used to treat bone diseases exert their
beneficial effects on these coordinated
functions. Examples of this coordination
requiring crosstalk between these two
distinct cell lineages include activation of
osteoclasts, and the coupling of bone
formation to prior bone resorption.
More is known about osteoclast activa-
tion than about coupling. Osteoclast acti-
vation is initiated and mediated by the
receptor activator of nuclear factor-kB
(RANK) ligand, a membrane-bound pro-
tein that is expressed by osteoblasts
and binds RANK on osteoclast precursors
(Boyle et al., 2003). The mechanisms
responsible for coupling remain unclear.
Some of the theories advanced over the
past 30 years to explain coordinated oste-
oclast and osteoblast activities during
coupling include (1) the release of growth
factors such as IGFs and/or TGFb from
the bone microenvironment as a conse-
quence of resorption, which attracts os-
teoblast precursors to sites of resorption,
stimulates their proliferation, and en-
hances their differentiation (Howard et al.,
1981); (2) ephrin-Eph bidirectional signal-
ing, whereby osteoblast differentiation is
stimulated by ephrin B2 expressed by
osteoclasts, which activates the receptor
Eph B4 on osteoblasts, while reverse sig-
naling leads to reduced osteoclast activity
(Zhao et al., 2006); (3) osteoclast-derived
factors that promote osteoblast prolifera-tion and differentiation (Parfitt et al., 1996;
Martin and Sims, 2005). None of these
explanations account for the in vivo
observations.
With this background, two particular
papers in Developmental Cell, considered
together, may throw new light on the
pathways that regulate osteoclast-osteo-
blast interactions. Both papers use ge-
netic mouse models to delete Patched
(Ptch), the membrane-bound molecule
that acts as a functional inhibitor of Hh
signaling, to address the role of enhanced
Hh signaling in postnatal bone cells. Ohba
et al. (2008) use mice with a Ptch haploin-
sufficiency that removes 50% of the
inhibition of Hh signaling in all Ptch-ex-
pressing cells from the earliest stages of
development. These mice have increased
bone mass primarily due to enhanced os-
teoblast differentiation, although osteo-
clastogenesis is also enhanced. Interest-
ingly, patients with nevoid basal cell
carcinoma syndrome, a disease caused
by Ptch haploinsufficiency, also have
increased bone mass. These authors
show that Gli3, a transcriptional repressor
downstream of Hh, inhibits Runx2, the
master regulator of osteoblast differentia-
tion, to control excessive osteoblast
differentiation in vitro. Although it remains
to be further defined in vivo, enhanced Hh
signaling in Ptch+/ mice likely reduces
the production of the truncated repressor
form of Gli3, which in turn reduces the re-
pression of Runx2 and osteoblast differ-
entiation, resulting in increased osteo-
blast activity and high bone mass. Mak
et al. (2008) on the other hand show that
conditional deletion of Ptch selectively in
mature osteoblasts enhances Hh signal-
ing and leads to increased osteoclasto-
genesis, so that the overall result isDevelopmentadecreased bone mass and osteopenia.
The authors further show that this osteo-
penic phenotype is a result of enhanced
Hh signaling in fully differentiated osteo-
blasts, which stimulates the production
of parathyroid hormone related protein
(PTHrP), and in turn activates Rankl ex-
pression which leads to increased osteo-
clast activity (Figure 1). Conditional dele-
tion of Smo, the active Hh receptor, in
mature osteoblasts leads to the opposite
effect.
Several factors may explain the appar-
ent discrepancies between the two pa-
pers. One is cell specificity: in the Ohba
et al. study, haploinsufficiency in cell line-
ages other than osteoblasts may indi-
rectly affect bone formation. Mak et al.
use a cell-specific promoter to target to
a subset of osteocalcin-expressing osteo-
blasts. An alternative explanation involves
the timing of Hh signaling, i.e. whether de-
letion of Ptch occurs in early or late oste-
oblasts. Lastly, a dose effect of Hh signal-
ing maybe responsible: Hh signaling in
Ptch haploinsufficiency may be less se-
verely affected (and enhanced) compared
with that of the conditional knockout
mice, wherein the Ptch knockout is likely
complete and Hh signaling is therefore
more greatly enhanced. However, it
should also be kept in mind that condi-
tional knockout models may not reflect
normal physiology or disease states,
although in this case they allow study
of temporal-spatial influences on bone
remodeling.
The experiments reported in these
papers do not allow us to distinguish
between these possible explanations,
and these results beg for further studies
to delineate the mechanisms whereby
Hh signaling controls postnatal bonel Cell 14, May 2008 ª2008 Elsevier Inc. 637
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PreviewsFigure 1. Hedgehog Signaling Regulates Postnatal Bone Remodeling
Under normal conditions, Hedgehog (Hh) signaling is downregulated during osteoblast (Obl) differentiation, which leads to normal bone remodeling and normal
bone mass. When Hh signaling is enhanced by Patched (Ptch) haploinsufficiency (1), increased osteoblast activity predominates over increased osteoclast
activity, resulting in high bone mass in mutant mice. However, when Hh signaling is enhanced specifically in differentiated osteoblasts (mObl) by Ptch deletion
(2), upregulation of PTHrP, activation of Creb-mediated Rankl transcription, increased osteoclastogenesis, and augmentation of bone resorption occurs, which
leads to osteopenia in mutant mice.remodeling. One immediately obvious ex-
periment would be to remove Ptch com-
pletely at an early stage of the osteoblast
lineage to enhance Hh signaling specifi-
cally in all cells of this lineage. If the net
outcome of such a manipulation resulted
in increased osteoblast differentiation
and hence increased bone mass, one
could then reasonably conclude that the
function of Hh signaling is autonomous
in osteoblasts and dose independent. If
however the net result was increased
osteoclastogenesis and bone resorption,
one could conclude a dose-dependent
and stage-independent function of Hh
signaling in the control of osteoclast and
osteoblast activities.
Notwithstanding these open issues,
these two studies raise some interesting
questions. For example, how could rates
of Hh signaling affect the coupling of oste-
oclast and osteoblast activities? Perhaps
Hh signaling allows exquisite regulation
of these activities in postnatal bone: high
Hh signaling favors bone resorption, while
somewhat lower levels of Hh signaling638 Developmental Cell 14, May 2008 ª200favor bone formation. If so, then what
are the mechanisms that control Hh sig-
naling in cells at different stages of the os-
teoblast lineage? There are a number of
possibilities, including factors produced
as a consequence of resorption, such as
TGFb and Wnts, both of which have
been shown to enhance expression of
Hh signaling molecules such as Gli2
(Charron and Tessier-Lavigne, 2007).
These factors would further amplify Hh
signaling and lead to increased osteo-
clastogenesis rather than bone formation.
It may be that in a complex situation
such as this, with multiple variables and
markedly different effects observed,
a systems approach using mathematical
modeling of the activities of osteoclasts
and osteoblasts may be helpful. For ex-
ample, estimates of rate equations of Hh
signaling may be critical to the overall ef-
fect observed, and whether it is predomi-
nantly osteoclastic or osteoblastic. Math-
ematical modeling may also allow ‘‘in
silico’’ testing of some hypotheses, help
reduce ambiguity, and point to further8 Elsevier Inc.experimentationmost likely to be informa-
tive.
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